Literature DB >> 18772195

Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.

Diana Zala1, Emilie Colin, Hélène Rangone, Géraldine Liot, Sandrine Humbert, Frédéric Saudou.   

Abstract

Huntingtin (htt), the protein mutated in Huntington's disease, is a positive regulatory factor for vesicular transport whose function is lost in disease. Here, we demonstrate that phosphorylation of htt at serine 421 (S421) restores its function in axonal transport. Using a strategy involving RNA (ribonucleic acid) interference and re-expression of various constructs, we show that polyQ (polyglutamine)-htt is unable to promote transport of brain-derived neurotrophic factor (BDNF)-containing vesicles, but polyQ-htt constitutively phosphorylated at S421 is as effective as the wild-type (wt) as concerns transport of these vesicles. The S421 phosphorylated polyQ-htt displays the wt function of inducing BDNF release. Phosphorylation restores the interaction between htt and the p150(Glued) subunit of dynactin and their association with microtubules in vitro and in cells. We also show that the IGF-1 (insulin growth factor type I)/Akt pathway by promoting htt phosphorylation compensates for the transport defect. This is the first description of a mechanism that restores the htt function altered in disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772195     DOI: 10.1093/hmg/ddn281

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  63 in total

1.  Mass spectrometric identification of novel posttranslational modification sites in Huntingtin.

Authors:  Gaofeng Dong; Eduardo Callegari; Christian J Gloeckner; Marius Ueffing; Hongmin Wang
Journal:  Proteomics       Date:  2012-06       Impact factor: 3.984

2.  The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.

Authors:  Yan Wang; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

Review 3.  Huntingtin as an essential integrator of intracellular vesicular trafficking.

Authors:  Juliane P Caviston; Erika L F Holzbaur
Journal:  Trends Cell Biol       Date:  2009-03-05       Impact factor: 20.808

Review 4.  Integrated regulation of motor-driven organelle transport by scaffolding proteins.

Authors:  Meng-meng Fu; Erika L F Holzbaur
Journal:  Trends Cell Biol       Date:  2014-06-18       Impact factor: 20.808

Review 5.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

Review 6.  Repeat expansion disease: progress and puzzles in disease pathogenesis.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

7.  NMDA receptor excitotoxicity: impact on phosphatase activity and phosphorylation of huntingtin.

Authors:  Michael R Jablonski; Lori Cooper; Dena A Jacob
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

8.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

9.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

10.  Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.

Authors:  Jose R Pineda; Raúl Pardo; Diana Zala; Hua Yu; Sandrine Humbert; Frédéric Saudou
Journal:  Mol Brain       Date:  2009-10-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.